DFS | OS | |||
---|---|---|---|---|
Variable | HR (95 % CI) | P value | HR (95 % CI) | P value |
Age (<50 vs ≥50) | 1.09 (0.60–1.90) | 0.70 | 1.24 (0.73–2.12) | 0.43 |
Oropharynx vs non-oropharynx | 1.30 (0.82–2.29) | 0.23 | 1.20 (0.73–2.10) | 0.40 |
T stage (T1/2 vs T3/4) | 0.91 (0.43–1.91) | 0.79 | 1.03 (0.47–2.27) | 0.98 |
N stage (0–1 vs 2–3) | 2.03 (1.26–3.28) | 0.01 | 2.11 (1.20–3.50) | 0.01 |
ECOG performance status (0 vs ≥1) | 1.50 (0.87–2.47) | 0.14 | 1.50 (0.87–2.58) | 0.14 |
P16 | 1.30 (0.73–2.51) | 0.34 | 1.36 (0.71–2.59) | 0.35 |
Ki-67 | 0.82 (0.51–1.33) | 0.42 | 0.95 (0.57–1.56) | 0.83 |
P53 | 0.99 (0.61–1.60) | 0.90 | 1.10 (0.67–1.82) | 0.67 |
Nuclear pMEK | 1.58 (0.93–2.07) | 0.09 | 1.70 (0.95–3.02) | 0.07 |
Cytoplasmic pMEK | 0.55 (0.32–0.92) | 0.02 | 0.48 (0.28–0.84) | 0.01 |